A crystal-ball view of healthcare in 2016

Patients with 3 or more adverse pregnancy outcomes had lower odds of postpartum contraceptive use in a PRAMS analysis of 222,412 individuals.

Risk factors cast a wide net in preeclampsia prediction, but biomarkers could add precision, according to Dallas Reed, MD.

Risa Kagan, MD, on why the menopause transition is a critical window for bone loss and how women can preserve bone mass.

This FAQ summarizes a Special Report discussion on testosterone pellet therapy in women and advice for hesitant prescribers.

In the premiere episode of Mind, Body, & the Pause, Soma Mandal, MD, is joined by Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG, to discuss the stages of the menopause transition.

Mental health, bias, and trauma shape sexual health visits, and histories should assess function, not just risk, according to Sameena Rahman, MD.

This FAQ summarizes a Special Report discussion on off-label testosterone dosing, application, cost, and lab monitoring in women.

This FAQ summarizes a Special Report discussion on how two experts decide who is a candidate for testosterone therapy in women, from symptoms and context to hormone state vs age.